Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Solithromycin PK in Healthy Adults
NCT02348424Phase 1Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- May 2015
- Primary completion
- Jan 2017
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of solithromycin in gonorrhea (2 arms), sponsored by National Institute of Allergy and Infectious Diseases. Primary endpoint: Pharmacokinetics of solithromycin in plasma and tissue fluids at Day 3. Started May 2015; status: completed.
02
Drugs
solithromycin
03
Conditions
gonorrhea
Beyond the preview
Go deeper on NCT02348424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02348424.